|
|
|
Top stories today: - Apple said to have delayed cheaper Vision Pro launch beyond 2027
- Perplexity launches dedicated hub to track election
- Novo's new obesity drug CagriSema aims for record weight loss
- Apple continues to lead global tablet market
- Dollar slips against all Group-of-10 peers ahead of U.S. election
- China's fiscal, infrastructure spending falls short of targets
|
|
|
0. Data and calendar |
| All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT). |
|
| All times are ET. |
|
Listen to our AI-generated podcast summarizing today's newsletter (beware the few hallucinations): |
| Bay Area Times Daily - Nov. 4, 2024 ► Play Online |
|
1. Apple said to have delayed cheaper Vision Pro launch beyond 2027 |
|
|
Relatedly, MacBook Pro with a "total redesign" is rumored to launch in 2026 |
|
|
Additionally, Warren Buffett reduced Apple holdings by 25% in Q3 |
|
|
| | Discover the gentle art of getting to "yes" in every part of life. Our free guide reveals simple but powerful techniques anyone can use at work, home, or anywhere in between: | Ask for (and get) what you deserve with confidence Turn difficult conversations into win-win outcomes Build stronger relationships while reaching agreements Master persuasion skills for everyday situations
| | *Sponsored. |
|
|
3. Perplexity launches dedicated hub to track election |
|
|
4. Novo's new obesity drug CagriSema aims for record weight loss |
|
25% weight loss is what the Danish drugmaker expected. The Semaglutide + Cagrilintide combination is currently in testing. Dec.: when a large study of CagriSema is due to read out. Eli Lilly's Zepbound set to compete against Novo's latest offering.
|
Novo's shares are -25% since its Jun. peak as the existing Ozempic and Wegovy drugs didn't meet market expectations |
|
5. Tablet shipments globally reach 39.6M units, with Apple continuing domination |
|
12.6M iPad units were shipped by Apple, +1.6% YoY. -16% in Apple's market share to 31.7% in Q3 from 37.7% a year ago. Samsung came 2nd, with 7.1M units shipped. Amazon was back in the top-5 list, with 4.6M shipments. +44.1% in Huawei's growth, with 3.2M shipments.
|
6. China's fiscal, infrastructure spending falls short of targets |
|
$3.7T (26.2T Yuan) in fiscal spending through Sep., slightly below last year's 26.4T Yuan spending. +3% in spending was projected this year. This week: Chinese lawmakers are deciding on the next stimulus package. Analysts aren't expecting a significant boost for the economy.
|
Chinese local govt. infrastructure funds are spending -15% less this year |
|
|
7. Dollar slips against all Group-of-10 peers ahead of U.S. election |
|
|
8. China EV stocks outperform global peers since Aug. |
|
+5.6% in BYD's share price on Mon. +6% in Xpeng and Geely Automobile stock prices. "Record high monthly deliveries" by quite a few players, a Nomura analyst said.
|
9. Interesting videos, posts, and memes |
| The 10 Trillion Parameter AI Model With 300 IQ |
|
|
| Secrets Of Investing Early – Lessons From A Billion-Dollar Investor |
|
|
| Inflated GDP?, Google earnings, How the media lost trust, Rogan/Trump search controversy, Election! |
|
|
| Fire your team and hire AI employees? |
|
|
10. Other headlines |
AI |
Microsoft, a16z propose AI policy for startups, stress cost-benefit regulation. Walt Disney forms business unit to coordinate use of AI, augmented reality. Intel CEO drops $500M+ Gaudi AI chip forecast for 2024. CoreWeave forecasts revenues to grow 4x to $8B in 2025: report.
|
|
Tech |
Apple to invest up to $1.5B in Globalstar for satellite coverage expansion. NVIDIA to replace Intel in Dow Jones Industrial Average. X now lets blocked users see your public posts.
|
|
Tech & law |
US CHIPS Act finalizes $123M grant from $33B+ amid bipartisan criticism. Elon Musk fails to dismiss ex-Twitter CEO Parag Agrawal's severance claim. TikTok sued by French families over alleged failure to remove harmful content.
|
Biotech |
Happy Aging introduces women-targeting longevity shot. Toray, Tsukuba join forces to advance longevity research. EU antitrust regulators to rule on Novo-Catalent deal by Dec. 6.
|
Business |
Oil gains $1+ after OPEC+ delays output hike. China urges EU on agreeable EV trade solution as France defends bloc. Mitsubishi, Nissan to establish JV on autonomous driving: report.
|
Crypto |
|
U.S. politics |
Selzer poll gives Harris +3 for Iowa. Trump at 53% odds according to Nate Silver's model. Trump +0.3% in PA, +0.1% nationally, according to RealClearPolling. Trump-betting whale: "I have absolutely no political agenda." Arizona prosecutor investigates Trump over Cheney-related gunfire remark. Trump wants RFK in administration, doesn't rule out banning certain vaccines. ~$1B has been spent on political ads over the last week.
|
World |
Iran said planning to use more powerful weapons in next attack on Israel. Israel ends agreement facilitating work of UNRWA, accused of terrorism ties. German foreign minister vows support as Ukraine enters 3rd winter of war. Moldova's pro-Western Sandu claims election win after meddling allegations.
|
Was this newsletter forwarded to you? Sign up here. Liked it? Forward it to friends and get rewards (see below). |
| Share Bay Area Times | Share our newsletter with your friends and get free Bay Area Times rewards! | You currently have 0 referrals, only 1 away from receiving our Generative AI Unicorns Database. | | | Or copy and paste this link to others: https://www.bayareatimes.com/subscribe?ref=UbEAXR818y | |
|
What did you think of today's newsletter? |
|
Advertise on the Bay Area Times |
Disclaimer: The Bay Area Times is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. You should do your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the Bay Area Times team. |
Please read our Terms of Service and our Privacy Policy before using Our Service. |
Comments
Post a Comment